Clinical trial
Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
NCT00003730 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003730 |
|---|---|
| Title | Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer |
| Official title | A Multicenter Randomized Trial, With Direct Individual Benefit, to Determine the Optimal Circadian Time of Vinorelbine Administration Combined With Chronomodulated Infusion of 5-Fluorouracil in Previously Treated Patients With Metastatic Breast Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, vinorelbine tartrate |
| Enrollment | 80 |
| Start date | Dec 1, 1998 |
| Primary completion | Nov 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 2, 2012 |
| Countries | Belgium, France, Greece, Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: